Kirenol attenuates pressure overload-induced heart failure by enhancing autophagy in macrophages
Authors:
- 4 August 2025
- journal article
- Published by Elsevier in International Journal of Cardiology
- Vol. 440, 133681
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82170386)
This publication has 24 references indexed in Scilit:
- Kirenol Ameliorates Myocardial Ischemia–Reperfusion Injury by Promoting Mitochondrial Function and Inhibiting Inflammasome ActivationCardiovascular Drugs and Therapy, 2024
- Inflammation in heart failure: pathophysiology and therapeutic strategiesInflammation Research, 2024
- Kirenol inhibits inflammation challenged by lipopolysaccharide through the AMPK-mTOR-ULK1 autophagy pathwayInternational Immunopharmacology, 2023
- Cannabidiol activates PINK1-Parkin-dependent mitophagy and mitochondrial-derived vesiclesEuropean Journal of Cell Biology, 2021
- ACC/AHA Versus ESC Guidelines on Heart FailureJACC, 2019
- Macrophages in Heart Failure with Reduced versus Preserved Ejection FractionTrends in Molecular Medicine, 2019
- Stressing out the mitochondria: Mechanistic insights into NLRP3 inflammasome activationJournal of Leukocyte Biology, 2018
- The role of Resveratrol-induced mitophagy/autophagy in peritoneal mesothelial cells inflammatory injury via NLRP3 inflammasome activation triggered by mitochondrial ROSExperimental Cell Research, 2016
- The pathogenesis of cardiac fibrosisCellular and Molecular Life Sciences, 2013
- Autophagy: Renovation of Cells and TissuesCell, 2011